Schizophrenia Research
Volume 78, Issue 2 , Pages 147-156, 15 October 2005

The European First Episode Schizophrenia Trial (EUFEST): Rationale and design of the trial

  • W. Wolfgang Fleischhacker

      Affiliations

    • Department of Biological Psychiatry, Medical University Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria
    • Corresponding Author InformationCorresponding author. Tel.: +43 512 504 23669; fax: +43 512 504 25267.
  • ,
  • Ireneus P.M. Keet

      Affiliations

    • Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands
  • ,
  • René S. Kahn

      Affiliations

    • Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center Utrecht, The Netherlands
  • ,
  • EUFEST Steering Committee

      Affiliations

    • The EUFEST Steering Committee: Austria: W. Wolfgang Fleischhacker, Principal Investigator (PI), Martina Hummer, Country Coordinator (CC) Department of Biological Psychiatry, Medical University Innsbruck, Innsbruck. Belgium: Jozef Peuskens (CC), Universitair Centrum St.-Jozef, Kortenberg. Bulgaria: Luchezar G. Hranov (CC ), University Hospital of Neurology and Psychiatry “St. Naum”, Sofia. Czech Republic: Jan Libiger (CC), Psychiatric Clinic and Department of Psychiatry, Charles University, Hradec Kralové. France: Sonja Dollfus (CC), Centre Esquirol-CHU de Caen, Caen Cedex. Germany: Wolfgang Gaebel (CC), Rheinische Kliniken Düsseldorf, Düsseldorf. Israel: Michael Davidson (CC), Sheba Medical Center, Tel Hashomer. Italy: Silvana Galderisi (CC), Department of Psychiatry, University of Naples SUN, Naples. Netherlands: René S. Kahn, Principal Investigator (PI) and Country coordinator (CC), University Medical Center Utrecht, Utrecht. I.P.M. Keet (Trial Co-ordinator until July 2004), Han Boter (current Trial Co-ordinator), University Medical Center Utrecht, Utrecht. Poland: Janusz Rybakowski (CC), Karol Marcinkowski University of Medical Sciences, Poznan. Romania: Mihai Gheorghe (CC), Central Military Hospital, Psychiatric Department, Bucharest. Spain: Juan-Jose Lopez Ibor (CC), Hospital Universitario San Carlos, Madrid. Sweden: Goran Sedvall (CC), Inst. Of Clinical Neuroscience, Psychiatry Section, Stockholm. Switzerland: Anita Riecher-Rössler (CC), Psychiatrische Universitätspoliklinik, Basel.

Received 12 May 2005; received in revised form 2 June 2005; accepted 3 June 2005.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-9964(05)00237-9

doi:10.1016/j.schres.2005.06.004

Schizophrenia Research
Volume 78, Issue 2 , Pages 147-156, 15 October 2005